BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17657675)

  • 1. Genotype Ser413/Ser of PAI-2 polymorphism Ser413/Cys is associated with anti-phospholipid syndrome and systemic lupus erythematosus in a familial case: comparison with healthy controls.
    Vázquez-Del Mercado M; García-Cobian TA; Muñoz Valle JF; Torres-Carrillo N; Martín-Márquez BT; Arana-Argaez VE; Best-Aguilera CR; Martínez-García EA; Petri MH; Núñez-Atahualpa L; Delgado-Rizo V
    Scand J Rheumatol; 2007; 36(3):206-10. PubMed ID: 17657675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
    Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome.
    Tàssies D; Espinosa G; Muñoz-Rodríguez FJ; Freire C; Cervera R; Monteagudo J; Maragall S; Escolar G; Ingelmo M; Ordinas A; Font J; Reverter JC
    Arthritis Rheum; 2000 Oct; 43(10):2349-58. PubMed ID: 11037896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus.
    Palafox-Sánchez CA; Vázquez-Del Mercado M; Orozco-Barocio G; García-De la Torre I; Torres-Carrillo N; Torres-Carrillo NM; Illades-Aguiar B; Muñoz-Valle JF
    Clin Appl Thromb Hemost; 2009; 15(2):233-8. PubMed ID: 18818228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
    Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PAL-1 5G/4G polymorphism in patients with systemic lupus erythematosus].
    Savov A; Andonova S; Tanev D; Robeva R; Marincheva Ts; Tomova A; Kumanov P; Rashkov R; Kolarov Z
    Akush Ginekol (Sofiia); 2014; 53(7):13-7. PubMed ID: 25675617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
    Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The -675 4G/5G
    Anaya-Macias BU; De la Cruz-Mosso U; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla G; González-López L; Gámez-Nava JI; Pérez-Guerrero EE; Barrientos-Avalos SL; Muñoz-Valle JF
    Autoimmunity; 2020 Mar; 53(2):71-77. PubMed ID: 31829037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province].
    Liu SQ; Xue YM; Yang GC; He FY; Zhao XS
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):904-7. PubMed ID: 15321757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
    Guan LX; Du XY; Wang JX; Wang RL; Wu ZL; Jiang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of PAI-1 gene polymorphism with prognosis of coronary artery disease].
    Zhang AY; Ji XW; Guan LX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):233-5. PubMed ID: 18393255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
    Ramón LA; Gilabert-Estellés J; Cosín R; Gilabert J; España F; Castelló R; Chirivella M; Romeu A; Estellés A
    Thromb Res; 2008; 122(6):854-60. PubMed ID: 18423526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype and allele frequency of PAI-1 promoter polymorphism in healthy subjects from the west of Mexico. Association with biochemical and hematological parameters.
    Ruiz-Quezada S; Vázquez-Del Mercado M; Parra-Rojas I; Rangel-Villalobos H; Best-Aguilera C; Sánchez-Orozco LV; Muñoz-Valle JF
    Ann Genet; 2004; 47(2):155-62. PubMed ID: 15183748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of PAI-1 promoter 4G/5G polymorphism in healthy Chinese and functional characterization using a luciferase reporter vector.
    Ding Z; Pan JQ
    Ann Hematol; 2005 Mar; 84(3):183-7. PubMed ID: 15309528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension.
    Roncal C; Orbe J; Rodriguez JA; Belzunce M; Beloqui O; Diez J; Páramo JA
    Cardiovasc Res; 2004 Jul; 63(1):176-85. PubMed ID: 15194475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thrombosis in patients with antiphospholipid syndrome].
    Aĭsina RB; Mukhametova LI; Ostriakova EV; Seredavkina NV; Patrushev LI; Patrusheva NL; Reshetniak TM; Gulin DA; Gershkovich KB; Nasonov EL; Varfolomeev SD
    Biomed Khim; 2014; 60(1):72-93. PubMed ID: 24749249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele.
    Balada E; Villarreal-Tolchinsky J; Ordi-Ros J; Labrador M; Serrano-Acedo S; Martinez-Lostao L; Vilardell-Tarrés M
    Tissue Antigens; 2006 Nov; 68(5):432-8. PubMed ID: 17092257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus.
    Lima G; Soto-Vega E; Atisha-Fregoso Y; Sánchez-Guerrero J; Vallejo M; Vargas-Alarcón G; Llorente L
    Hum Immunol; 2007 Dec; 68(12):980-5. PubMed ID: 18191726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between the polymorphism at the heat-shock protein (HSP70-2) gene and systemic lupus erythematosus (SLE) in the Mexican mestizo population.
    Vargas-Alarcón G; Granados J; Martínez-Laso J; Gómez-Casado E; Zuñiga J; Salgado N; Hernández-Pacheco G; Hesiquio R; Rodríguez-Reyna TS; Gamboa R; Alcocer-Varela J; Arnaiz-Villena A
    Genes Immun; 2000 Aug; 1(6):367-70. PubMed ID: 11196683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAI-1 gene: pharmacogenetic association of 4G/4G genotype with bleeding after cardiac surgery--pilot study.
    Sirgo G; Morales P; Rello J
    Eur J Anaesthesiol; 2009 May; 26(5):404-11. PubMed ID: 19521296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.